Review Article
ROS and Brain Diseases: The Good, the Bad, and the Ugly
Table 1
Drugs with anti-inflammatory and antioxidant effects currently under investigation for the treatment of several neuropsychiatric diseases.
| Drug | Brain disease | Mechanism | Reference |
| -3 PUFA | ADHD | Nonspecific antioxidant effect | [151, 152] | Vitamin C | Vascular dementia | Free radical scavenger | [153] | Hyperbaric O2 | Autism | Anti-inflammatory and reduces oxidative stress | [157] | H2S | Focal cerebral ischemia/reperfusion | Inhibits oxidative phosphorylation, inflammation, and apoptosis | [159] | H2-rich saline | Focal or global cerebral ischemia/reperfusion | Reduces oxidative stress and inflammation | [160, 161] | Lithium | Healthy volunteers | Prevents/or reverses DNA damage, lipid peroxidation, and free radical formation | [164] | Pifithrin- | Perinatal hypoxic-ischemic brain damage | Inhibition of the apoptotic pathways and reduction of the oxidative stress | [166] | Telmisartan | Vascular dementia | Anti-inflammatory and antioxidant effects | [174–176] | Nanodrugs | | ROS scavengers | [177] | Triterpenoids | Parkinson | Antioxidants via Nrf2/ARE pathway | [146] | PPARgamma agonists | Neurodegenerative diseases | Anti-inflammatory | [162–164] |
|
|